{"data":{"id":"us/21-cfr-601.7","jurisdiction":"us","citation":"21 CFR 601.7","heading":"Procedure for hearings.","body":"(a) A notice of opportunity for hearing, notice of appearance and request for hearing, and grant or denial of hearing for a biological drug pursuant to this part, for which the exemption from the Federal Food, Drug, and Cosmetic Act in § 310.4 of this chapter has been revoked, shall be subject to the provisions of § 314.200 of this chapter except to the extent that the notice of opportunity for hearing on the matter issued pursuant to § 12.21(b) of this chapter specifically provides otherwise.\n(b) Hearings pursuant to §§ 601.4 through 601.6 shall be governed by part 12 of this chapter.\n(c) When a license has been suspended pursuant to § 601.6 and a hearing request has been granted, the hearing shall proceed on an expedited basis.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 601—LICENSING","Subpart A—General Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"7e88b4b230351347c8341028db4e3d52145891535abfabc431ae51e1f4abf932","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-601.6","next":"us/21-cfr-601.8"},"notice":"GroundRules: Original legal text. Not legal advice."}